All In MedTech

Company

Insulet

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Insulet is on our public-company list (ticker PODD). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

PODD

Nasdaq · INSULET CORP

Public float

$22.1B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$2.71B

Fiscal year ending Dec 31, 2025

Net income

$247M

Fiscal year ending Dec 31, 2025

R&D spending

$301M

Fiscal year ending Dec 31, 2025

Cash

$584M

As of Sep 30, 2026

Long-term debt

$943M

As of Sep 30, 2026

Shares outstanding

69.4M

As of Oct 27, 2026

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Insulet we have 4 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 19 since 2015.

Search the Clearance Tracker

16 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

20 more trials with a free account

Reports received

92,464

Received Nov 1, 2025 to Nov 20, 2026. Includes 92 of another or unstated type.

Malfunction reports

82,010

89% of reports

Injury reports

10,234

11% of reports

Death reports

128

0.1% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 232,99233720
Jan 243,18042930
Feb 243,52841830
Mar 243,44333610
Apr 243,95839310
May 244,11342601
Jun 243,67433301
Jul 244,97039121
Aug 244,75443020
Sep 244,51032901
Oct 244,49243110
Nov 243,54538930
Dec 243,26937410
Jan 254,21444730
Feb 253,64236110
Mar 254,75749820
Apr 254,49050311
May 254,20843030
Jun 254,99351430
Jul 254,87948100
Aug 254,11643510
Sep 255,78552830
Oct 257,23858120
Nov 255,98349470
Dec 255,15959540
Jan 264,35447730
Feb 265,59353430
Mar 265,73263170
Apr 266,600960140
May 266,132935120
Jun 267,9591,185120
Jul 269,8301,3463030
Aug 269,3301,1731921
Sep 268,9431,0471320
Oct 266,395857421
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

2 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

18 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.